Agency places more holds on trials to protect patients, ensure studies are designed properly, Wall Street Journal review findsPhoto:The Food and Drug Administration is pressing pause on drug-company testing of experimental medicines more often, a side effect of the industry’s move into promising but less-proven technologies.
The agency, which must sign off before companies can begin testing an experimental drug in people, has long used its authority to place holds on studies due to safety concerns. As biotechs pursue more cutting-edge cell and gene therapies, the FDA has been issuing more suspensions than it had, according to a Wall Street Journal review of FDA data on clinical holds, some of which was obtained through a Freedom of Information Act request.
Maybe they should pause the study of the experimental vaccine for Covid before they do anything else.
If it’s for safety, I don’t see how this is a bad thing.
Funny how the experimental medication gets the scrutiny, not the mandating it be taken part.
Biden has weaponized the entire government. So dangerous that he was ever permitted to steal the presidency. The FDA has no problem approving the big pharma drugs that will kill you. When small guy seek solutions, they stop or pause studies while people are actively participating
Better scrutinizing drugs by FDA is much safer than the rushed warp speed approvals over the past 3 years. 👍
When 'it's an emergency!'🚨🚨🚨 All the high standards go through the window.When the WHO declares 'health emergency of international concern' IT HAS IMPLICATIONS beyond whatever the fks decided to call it. It pretty much allows to glue it together with saliva and start the sales
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Sumber: CNBC - 🏆 12. / 72 Baca lebih lajut »
Sumber: MarketWatch - 🏆 3. / 97 Baca lebih lajut »